Page last updated: 2024-08-23

epirubicin and Astrocytoma, Grade IV

epirubicin has been researched along with Astrocytoma, Grade IV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cabral, H; Kataoka, K; Kinoh, H; Liu, X; Maity, A; Quader, S; Shibasaki, H; Yamasoba, T1
Cabral, H; Chen, Y; Chida, T; Ishii, T; Kataoka, K; Liu, X; Mi, P; Miura, Y; Nishiyama, N; Quader, S1
Graham, RM; Hettiarachchi, SD; Leblanc, RM; Mintz, KJ; Peng, Z; Vanni, S; Zhou, Y1
Ju, RJ; Liu, L; Lu, WL; Mu, LM; Xie, HJ; Yan, Y; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y1
Chang, J; Han, L; Kang, C; Liao, Z; Pu, P; Su, W; Wang, G; Wang, H; Wang, S; Wang, X1
Drummond, DC; Guo, Z; Hong, K; Kallab, V; Kirpotin, DB; Mamot, C; Noble, CO; Park, JW1

Other Studies

6 other study(ies) available for epirubicin and Astrocytoma, Grade IV

ArticleYear
Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative Glioblastoma.
    ACS nano, 2020, 08-25, Volume: 14, Issue:8

    Topics: Brain Neoplasms; Cell Line, Tumor; Epirubicin; Glioblastoma; Humans; Micelles; Nanomedicine; Neoplastic Stem Cells; PTEN Phosphohydrolase; Tumor Microenvironment

2020
cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 07-28, Volume: 258

    Topics: Animals; Antibiotics, Antineoplastic; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Epirubicin; Female; Glioblastoma; Humans; Mice, Inbred BALB C; Micelles; Peptides, Cyclic; Polyethylene Glycols

2017
Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors.
    Nanoscale, 2019, Mar-28, Volume: 11, Issue:13

    Topics: Brain Neoplasms; Carbon; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Synergism; Epirubicin; Glioblastoma; Humans; Models, Biological; Quantum Dots; Spectrometry, Fluorescence; Temozolomide; Transferrin

2019
A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Endothelial Cells; Epirubicin; Glioblastoma; Glucosides; Humans; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Peptides, Cyclic; Spheroids, Cellular; Time Factors; Tissue Distribution; Xenograft Model Antitumor Assays

2015
Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
    Nanoscale, 2012, Oct-21, Volume: 4, Issue:20

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Epirubicin; Gene Transfer Techniques; Glioblastoma; Green Fluorescent Proteins; Humans; Lactic Acid; Magnetite Nanoparticles; Nanospheres; Plasmids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Spectroscopy, Fourier Transform Infrared; Stomach; Xenograft Model Antitumor Assays

2012
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Cancer research, 2005, Dec-15, Volume: 65, Issue:24

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cetuximab; Doxorubicin; Drug Delivery Systems; Epirubicin; ErbB Receptors; Female; Glioblastoma; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Liposomes; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine

2005